Abstract

Dynamics of clinical and immunological parameters in patients underwent a moderate COVID-19 and received therapy with janus kinase inhibitor

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call